Atea Pharmaceuticals, Inc.(AVIR)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

AVIR Atea Pharmaceuticals, Inc.

盘后交易 05-06 19:46:08 EDT

4.00

+0.04

+1.01%

盘后4.00

+0.000.00%

16:16 EDT

最高4.00	最低3.89	成交量28.82万
今开3.96	昨收3.96	日振幅2.90%
总市值3.37亿	流通市值2.55亿	总股本8,422万
成交额114.12万	换手率0.45%	流通股本6,372万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"AVIR","market":"US","secType":"STK","nameCN":"Atea Pharmaceuticals, Inc.","latestPrice":4,"timestamp":1715025600000,"preClose":3.96,"halted":0,"volume":288222,"hourTrading":{"tag":"盘后","latestPrice":4,"preClose":4,"latestTime":"16:16 EDT","volume":63490,"amount":253960,"timestamp":1715026589532},"delay":0,"floatShares":63720856,"shares":84223100,"eps":-1.630368,"marketStatus":"盘后交易","marketStatusCode":4,"change":0.04,"latestTime":"05-06 19:46:08 EDT","open":3.96,"high":4,"low":3.885,"amount":1141213.164379,"amplitude":0.02904,"askPrice":4.04,"askSize":3,"bidPrice":3.86,"bidSize":3,"shortable":3,"etf":0,"ttmEps":-1.630368,"exchange":"NASDAQ","tradingStatus":3,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1715040000000},"adr":0,"listingDate":1604030400000,"adjPreClose":3.96,"adrRate":0,"postHourTrading":{"tag":"盘后","latestPrice":4,"preClose":4,"latestTime":"16:16 EDT","volume":63490,"amount":253960,"timestamp":1715026589532},"volumeRatio":1.26534},"requestUrl":"/m/hq/s/AVIR/tweets","defaultTab":"tweets","newsList":[{"id":"2420747725","title":"Atea Pharmaceuticals, Inc.盘中异动 早盘大幅下跌5.84%","url":"https://stock-news.laohu8.com/highlight/detail?id=2420747725","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2420747725?lang=zh_cn&edition=full","pubTime":"2024-03-20 21:31","pubTimestamp":1710941477,"startTime":"0","endTime":"0","summary":"北京时间2024年03月20日21时31分，Atea Pharmaceuticals, Inc.股票出现异动，股价急速下跌5.84%。Atea Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为0.41%。Atea Pharmaceuticals, Inc.公司简介：Atea Pharmaceuticals Inc 是一家临床阶段的生物制药公司，专注于发现、开发和商业化抗病毒疗法，以改善患有严重病毒感染的患者的生活。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240320213117879d61c5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240320213117879d61c5&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2416302140","title":"Atea Pharmaceuticals, Inc.盘中异动 股价大跌5.06%报4.23美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2416302140","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2416302140?lang=zh_cn&edition=full","pubTime":"2024-03-04 23:06","pubTimestamp":1709564773,"startTime":"0","endTime":"0","summary":"北京时间2024年03月04日23时06分，Atea Pharmaceuticals, Inc.股票出现波动，股价快速下挫5.06%。截至发稿，该股报4.23美元/股，成交量2.8392万股，换手率0.03%，振幅5.62%。Atea Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.06%。Atea Pharmaceuticals, Inc.公司简介：Atea Pharmaceuticals Inc 是一家临床阶段的生物制药公司，专注于发现、开发和商业化抗病毒疗法，以改善患有严重病毒感染的患者的生活。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024030423061379171adc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024030423061379171adc&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2416909550","title":"Atea Pharmaceuticals, Inc.2023财年实现净利润-1.36亿美元，同比减少17.24%","url":"https://stock-news.laohu8.com/highlight/detail?id=2416909550","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2416909550?lang=zh_cn&edition=full","pubTime":"2024-03-04 00:27","pubTimestamp":1709483225,"startTime":"0","endTime":"0","summary":"12月31日，Atea Pharmaceuticals, Inc.公布财报，公告显示公司2023财年净利润为-1.36亿美元，同比减少17.24%；其中营业收入为0.00美元，每股基本收益为-1.63美元。机构评级：截至2023年12月31日，当前有2家机构对Atea Pharmaceuticals, Inc.目标价做出预测，其中目标均价为3.50美元，其中最低目标价为2.00美元，最高目标价为5.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024030400271487e0e72b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024030400271487e0e72b&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2416786629","title":"Atea Pharmaceuticals, Inc.盘中异动 急速拉升5.10%","url":"https://stock-news.laohu8.com/highlight/detail?id=2416786629","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2416786629?lang=zh_cn&edition=full","pubTime":"2024-03-02 01:03","pubTimestamp":1709312594,"startTime":"0","endTime":"0","summary":"北京时间2024年03月02日01时03分，Atea Pharmaceuticals, Inc.股票出现波动，股价快速上涨5.10%。Atea Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为2.58%。Atea Pharmaceuticals, Inc.公司简介：Atea Pharmaceuticals Inc 是一家临床阶段的生物制药公司，专注于发现、开发和商业化抗病毒疗法，以改善患有严重病毒感染的患者的生活。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024030201031479166597&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024030201031479166597&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2415541152","title":"美国研究综述-Inhibrx、LSB Industries、Xencor","url":"https://stock-news.laohu8.com/highlight/detail?id=2415541152","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2415541152?lang=zh_cn&edition=full","pubTime":"2024-02-29 20:56","pubTimestamp":1709211391,"startTime":"0","endTime":"0","summary":"    路透社2月29日 - 华尔街证券分析师周四调整了对几家美国上市公司的评级和目标价，其中包括 Inhibrx、LSB Industries 和 Xencor。* Inhibrx Inc   ：杰富瑞将其评级从 \"买入 \"下调至 \"持有 * LSB Industries Inc   ：Piper Sandler将其评级从 \"中性 \"下调至 \"减持\"。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2415056730","title":"美国研究综述-Okta、Salesforce、Sarepta Therapeutics","url":"https://stock-news.laohu8.com/highlight/detail?id=2415056730","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2415056730?lang=zh_cn&edition=full","pubTime":"2024-02-29 15:07","pubTimestamp":1709190420,"startTime":"0","endTime":"0","summary":"    路透社2月29日 - 华尔街证券分析师周四调整了对几家美国上市公司的评级和目标价，其中包括 Okta、Salesforce 和 Sarepta Therapeutics。要点             * Clearwater Analytics Holdings Inc   ：摩根大通将其评级从 \"增持 \"下调至 \"中性             * Okta Inc   ：Piper Sandler将目标价从85美元上调至110美元              * Salesforce Inc   ：巴克莱将目标价从325美元上调至355美元              * Sarepta Therapeutics Inc   ：Leerink Partners将目标价从145美元上调至165美元              * Universal Health Services Inc   ：Leerink Partners将目标价从174美元上调至192美元  以下是路透社周四报道的美国公司研究行动摘要。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2415556195","title":"Atea Pharmaceuticals Inc 报告截至 12 月的季度业绩 - 收益摘要","url":"https://stock-news.laohu8.com/highlight/detail?id=2415556195","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2415556195?lang=zh_cn&edition=full","pubTime":"2024-02-29 10:27","pubTimestamp":1709173625,"startTime":"0","endTime":"0","summary":"   * Atea Pharmaceuticals Inc   报告，截至12月底的季度调整后每股亏损47美分，低于去年同期的每股收益-41美分。四位分析师对该季度的平均预期是每股亏损 50 美分。华尔街预期为每股-52美分至-48美分。* Atea Pharmaceuticals Inc 公布的季度每股收益为亏损 47 美分。* 该公司当季亏损 3,870 万美元。* Atea Pharmaceuticals Inc 的股价本季度上涨了 49.5%。华尔街对 Atea Pharmaceuticals Inc 的 12 个月目标价中位数为 3.00 美元。(如对本报告中的数据有任何疑问，请联系 Estimates.Support@lseg.com。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2415719073","title":"Atea Pharmaceuticals Inc盘中异动 早盘大幅下挫5.04%报4.33美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2415719073","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2415719073?lang=zh_cn&edition=full","pubTime":"2024-02-29 00:12","pubTimestamp":1709136720,"startTime":"0","endTime":"0","summary":"北京时间2024年02月29日00时12分，Atea Pharmaceuticals Inc股票出现波动，股价快速下跌5.04%。截至发稿，该股报4.33美元/股，成交量16.0298万股，换手率0.19%，振幅4.71%。Atea Pharmaceuticals Inc股票所在的生物技术行业中，整体跌幅为0.40%。其相关个股中，Vivani Medical Inc、Adial Pharmaceuticals Inc、Vtv Therapeutics Inc涨幅较大，Adial Pharmaceuticals Inc、Vivani Medical Inc、Zyversa Therapeutics Inc较为活跃，换手率分别为4152.30%、187.08%、79.42%，振幅较大的相关个股有Vivani Medical Inc、Adial Pharmaceuticals Inc、Ys Biopharma Co Ltd C/Wts 15/03/2028 ，振幅分别为350.50%、219.84%、93.93%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240229001200861d9ae9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240229001200861d9ae9&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2414296865","title":"Atea Pharmaceuticals Inc    预计每股亏损 50 美分 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2414296865","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2414296865?lang=zh_cn&edition=full","pubTime":"2024-02-27 06:30","pubTimestamp":1708986609,"startTime":"0","endTime":"0","summary":"   * Atea Pharmaceuticals Inc    将于2月28日公布截至2023年12月31日的财报，预计季度收入将保持不变。*    * LSEG分析师对Atea Pharmaceuticals Inc的平均预期是每股亏损50美分。* 华尔街对 Atea Pharmaceuticals Inc 的 12 个月目标价中位数为 3.00 美元，低于其上次收盘价 4.20 美元。2月26日 - 上一季度业绩。除非另有说明，否则所有数据均以美元为单位。(如对本报告中的数据有任何疑问，请联系 Estimates.Support@lseg.com。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2413438023","title":"Atea Pharmaceuticals Inc盘中异动 股价大涨5.10%","url":"https://stock-news.laohu8.com/highlight/detail?id=2413438023","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2413438023?lang=zh_cn&edition=full","pubTime":"2024-02-21 04:57","pubTimestamp":1708462622,"startTime":"0","endTime":"0","summary":"北京时间2024年02月21日04时57分，Atea Pharmaceuticals Inc股票出现波动，股价急速拉升5.10%。截至发稿，该股报4.33美元/股，成交量30.7678万股，换手率0.37%，振幅5.10%。Atea Pharmaceuticals Inc股票所在的生物技术行业中，整体跌幅为0.78%。Atea Pharmaceuticals Inc公司简介：Atea Pharmaceuticals Inc 是一家临床阶段的生物制药公司，专注于发现、开发和商业化抗病毒疗法，以改善患有严重病毒感染的患者的生活。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202402210457027a450bd2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202402210457027a450bd2&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2411639598","title":"Atea Pharmaceuticals Inc盘中异动 快速下跌5.07%报3.93美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2411639598","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2411639598?lang=zh_cn&edition=full","pubTime":"2024-02-14 02:51","pubTimestamp":1707850297,"startTime":"0","endTime":"0","summary":"北京时间2024年02月14日02时51分，Atea Pharmaceuticals Inc股票出现波动，股价大幅跳水5.07%。截至发稿，该股报3.93美元/股，成交量13.4785万股，换手率0.16%，振幅2.90%。Atea Pharmaceuticals Inc股票所在的生物技术行业中，整体跌幅为1.03%。Atea Pharmaceuticals Inc公司简介：Atea Pharmaceuticals Inc 是一家临床阶段的生物制药公司，专注于发现、开发和商业化抗病毒疗法，以改善患有严重病毒感染的患者的生活。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240214025137861d51cb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240214025137861d51cb&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2408945593","title":"Atea Pharmaceuticals Inc盘中异动 急速拉升5.04%","url":"https://stock-news.laohu8.com/highlight/detail?id=2408945593","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2408945593?lang=zh_cn&edition=full","pubTime":"2024-02-01 03:35","pubTimestamp":1706729727,"startTime":"0","endTime":"0","summary":"北京时间2024年02月01日03时35分，Atea Pharmaceuticals Inc股票出现异动，股价快速上涨5.04%。截至发稿，该股报4.28美元/股，成交量36.2157万股，换手率0.43%，振幅5.41%。Atea Pharmaceuticals Inc股票所在的生物技术行业中，整体涨幅为0.21%。Atea Pharmaceuticals Inc公司简介：Atea Pharmaceuticals Inc 是一家临床阶段的生物制药公司，专注于发现、开发和商业化抗病毒疗法，以改善患有严重病毒感染的患者的生活。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024020103352787e6aa8b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024020103352787e6aa8b&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2406227341","title":"Atea Pharmaceuticals Inc盘中异动 大幅上涨5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2406227341","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2406227341?lang=zh_cn&edition=full","pubTime":"2024-01-26 04:58","pubTimestamp":1706216334,"startTime":"0","endTime":"0","summary":"北京时间2024年01月26日04时58分，Atea Pharmaceuticals Inc股票出现异动，股价快速上涨5.00%。截至发稿，该股报3.78美元/股，成交量28.0989万股，换手率0.34%，振幅5.56%。Atea Pharmaceuticals Inc股票所在的生物技术行业中，整体涨幅为0.42%。Atea Pharmaceuticals Inc公司简介：Atea Pharmaceuticals Inc 是一家临床阶段的生物制药公司，专注于发现、开发和商业化抗病毒疗法，以改善患有严重病毒感染的患者的生活。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240126045855790c2ee4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240126045855790c2ee4&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2406420429","title":"Atea Pharmaceuticals Inc盘中异动 下午盘急速下跌5.27%报3.59美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2406420429","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2406420429?lang=zh_cn&edition=full","pubTime":"2024-01-25 02:42","pubTimestamp":1706121742,"startTime":"0","endTime":"0","summary":"北京时间2024年01月25日02时42分，Atea Pharmaceuticals Inc股票出现异动，股价急速跳水5.27%。截至发稿，该股报3.59美元/股，成交量29.5152万股，换手率0.35%，振幅5.54%。Atea Pharmaceuticals Inc股票所在的生物技术行业中，整体跌幅为0.78%。其相关个股中，Evaxion Biotech As、Scisparc Ltd、Kura Oncology Inc涨幅较大，Scisparc Ltd、Evaxion Biotech As、Ensysce Biosciences Inc较为活跃，换手率分别为4754.04%、719.89%、342.19%，振幅较大的相关个股有Evaxion Biotech As、Revelation Biosciences Inc、Scisparc Ltd，振幅分别为104.21%、52.27%、48.27%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240125024222790bd39b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240125024222790bd39b&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2405127477","title":"Atea Pharmaceuticals Inc盘中异动 股价大涨5.11%","url":"https://stock-news.laohu8.com/highlight/detail?id=2405127477","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2405127477?lang=zh_cn&edition=full","pubTime":"2024-01-23 22:44","pubTimestamp":1706021059,"startTime":"0","endTime":"0","summary":"北京时间2024年01月23日22时44分，Atea Pharmaceuticals Inc股票出现波动，股价大幅上涨5.11%。截至发稿，该股报3.81美元/股，成交量14.9984万股，换手率0.18%，振幅5.11%。Atea Pharmaceuticals Inc股票所在的生物技术行业中，整体跌幅为0.33%。Atea Pharmaceuticals Inc公司简介：Atea Pharmaceuticals Inc 是一家临床阶段的生物制药公司，专注于发现、开发和商业化抗病毒疗法，以改善患有严重病毒感染的患者的生活。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240123224420790b70a1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240123224420790b70a1&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2402098634","title":"Atea Pharmaceuticals Inc盘中异动 股价大涨5.02%报3.52美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2402098634","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2402098634?lang=zh_cn&edition=full","pubTime":"2024-01-12 01:53","pubTimestamp":1704995612,"startTime":"0","endTime":"0","summary":"北京时间2024年01月12日01时53分，Atea Pharmaceuticals Inc股票出现波动，股价急速拉升5.02%。截至发稿，该股报3.52美元/股，成交量35.4843万股，换手率0.43%，振幅5.67%。Atea Pharmaceuticals Inc股票所在的生物技术行业中，整体跌幅为0.39%。Atea Pharmaceuticals Inc公司简介：Atea Pharmaceuticals Inc 是一家临床阶段的生物制药公司，专注于发现、开发和商业化抗病毒疗法，以改善患有严重病毒感染的患者的生活。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024011201533287e64f26&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024011201533287e64f26&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2402139054","title":"Atea Pharmaceuticals Inc盘中异动 早盘大幅上涨5.16%","url":"https://stock-news.laohu8.com/highlight/detail?id=2402139054","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2402139054?lang=zh_cn&edition=full","pubTime":"2024-01-09 22:41","pubTimestamp":1704811263,"startTime":"0","endTime":"0","summary":"北京时间2024年01月09日22时41分，Atea Pharmaceuticals Inc股票出现异动，股价急速上涨5.16%。截至发稿，该股报3.26美元/股，成交量14.9245万股，换手率0.18%，振幅3.87%。Atea Pharmaceuticals Inc股票所在的生物技术行业中，整体跌幅为0.54%。Atea Pharmaceuticals Inc公司简介：Atea Pharmaceuticals Inc 是一家临床阶段的生物制药公司，专注于发现、开发和商业化抗病毒疗法，以改善患有严重病毒感染的患者的生活。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202401092241037a39a609&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202401092241037a39a609&s=b","is_publish_highlight":false,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.ateapharma.com","stockEarnings":[{"period":"1week","weight":0.0674},{"period":"1month","weight":0.0154},{"period":"3month","weight":-0.0388},{"period":"6month","weight":0.211},{"period":"1year","weight":0.1892},{"period":"ytd","weight":0.2984}],"compareEarnings":[{"period":"1week","weight":0.006},{"period":"1month","weight":-0.0156},{"period":"3month","weight":0.0343},{"period":"6month","weight":0.1762},{"period":"1year","weight":0.262},{"period":"ytd","weight":0.0757}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Atea Pharmaceuticals, Inc.于2012年7月注册成立，并于2014年3月开始主要运营。该公司是一家临床阶段的生物制药公司，致力于发现，开发和商业化抗病毒治疗剂，以改善遭受威胁生命的病毒感染的患者的生活。","yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":0.218105},{"month":2,"riseRate":0.5,"avgChangeRate":-0.06977},{"month":3,"riseRate":0.25,"avgChangeRate":-0.039529},{"month":4,"riseRate":0,"avgChangeRate":-0.223714},{"month":5,"riseRate":0.75,"avgChangeRate":0.114814},{"month":6,"riseRate":0.333333,"avgChangeRate":-0.036577},{"month":7,"riseRate":0.666667,"avgChangeRate":0.079259},{"month":8,"riseRate":0.333333,"avgChangeRate":0.027042},{"month":9,"riseRate":0.333333,"avgChangeRate":-0.056266},{"month":10,"riseRate":0.666667,"avgChangeRate":-0.176728},{"month":11,"riseRate":0.25,"avgChangeRate":-0.126274},{"month":12,"riseRate":1,"avgChangeRate":0.101156}],"exchange":"NASDAQ","name":"Atea Pharmaceuticals, Inc.","nameEN":"Atea Pharmaceuticals, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.22.4","shortVersion":"4.22.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Atea Pharmaceuticals, Inc.(AVIR)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Atea Pharmaceuticals, Inc.(AVIR)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Atea Pharmaceuticals, Inc.,AVIR,Atea Pharmaceuticals, Inc.股票,Atea Pharmaceuticals, Inc.股票老虎,Atea Pharmaceuticals, Inc.股票老虎国际,Atea Pharmaceuticals, Inc.行情,Atea Pharmaceuticals, Inc.股票行情,Atea Pharmaceuticals, Inc.股价,Atea Pharmaceuticals, Inc.股市,Atea Pharmaceuticals, Inc.股票价格,Atea Pharmaceuticals, Inc.股票交易,Atea Pharmaceuticals, Inc.股票购买,Atea Pharmaceuticals, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Atea Pharmaceuticals, Inc.(AVIR)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Atea Pharmaceuticals, Inc.(AVIR)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}